DOBUTAMIN

A Drug Study Presented to the

Faculty of the Nursing Department
SARAH JANE PAMALOAN, RN

In Partial Fulfillment of 

the Requirements in NCM 214 RLE
OXYGENATION/FLUIDS AND ELECTROLYTES NURSING ROTATION

Submitted by:

BSN 3G – Group 1 Subgroup 1

October 13, 2022

 GENERIC NAME
BRAND NAME
PREGNANCY RISK
CATEGORY
CLASSIFICATION

MODE OF ACTION
SUGGESTED DOSE
INDICATIONS
CONTRAINDICATIONS
SIDE EFFECT
ADVERSE EFFECT
DRUG INTERACTION
NURSING Patient Monitoring:
RESPONSIBILITIES
Health Teachings:

REFERENCES